Skip to content

The CARMA Technique Study

The Cap-Assisted Resection Margin Assessment (CARMA) Technique After Polyp Resection: a Prospective Feasibility Study of a Novel Approach to Reduce Polyp Recurrence

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05099432
Enrollment
60
Registered
2021-10-29
Start date
2021-11-30
Completion date
2026-11-30
Last updated
2021-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonic Polyp, Colonic Sessile Serrated Lesion

Brief summary

Colonoscopic removal of polyps is an important and well-established tool in the prevention of colorectal cancers. However, high polyp recurrence rates after endoscopic resection, with resultant development of interval cancers, remains a problem; this most commonly stems from unrecognised incomplete polyp resection. Thus, a standardised endoscopic technique is needed that will allow endoscopists to consistently achieve a clear margin of resection. The investigators believe the Cap Assisted Resection Margin Assessment (CARMA) technique will address this problem. This novel technique focuses on a standardised assessment of the resection margin after endoscopic polypectomy utilising available standard high-definition video endoscopes with imaging features including narrow band imaging (NBI) and magnification endoscopy.

Interventions

PROCEDURECARMA technique

Once standard polyp resection and assessment of the polypectomy site without magnification is completed, the CARMA technique will be applied. This will involve an assessment of the entire polypectomy margin using cap assisted magnification endoscopy with the ability to also use NBI (at the endoscopist's discretion) and documentation of any residual polyp noted.

Sponsors

Princess Alexandra Hospital, Brisbane, Australia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patients with colonic polyps will be considered following below criteria Inclusion Criteria: \- any polypectomy (though only a maximum of two polyps from one individual participant)

Exclusion criteria

* polyps less than 10mm which were resected under endoscopic view with a definite \> 1mm clear margin * scar site recurrence polyps * polyps with endoscopic evidence of invasion * pedunculated polyps * pseudopolyps * participants who will not be available for follow up endoscopy

Design outcomes

Primary

MeasureTime frame
Rate of achieving a clear resection margin using the CARMA techniqueEstablished during index procedure

Secondary

MeasureTime frame
Frequency of residual polyp without CARMA assessmentEstablished during index procedure
Incomplete resection rate with use of CARMA techniqueEstablished during index procedure
Incomplete resection rate with use of the CARMA technique in polyps > 10mm with hot snareEstablished during index procedure
Incomplete resection rate with use of the CARMA technique in polyps > 10mm with cold snareEstablished during index procedure
Residual polyp rate after CARMA technique with hot snareEstablished during index procedure
Sensitivity and specificity of the CARMA technique for residual polyp detectionEstablished during index procedure
Time required for application of the CARMA technique with < 10mmEstablished during index procedure
Time required for application of the CARMA technique with > 10mmEstablished during index procedure
Polyp recurrence rate for < 10mm polypsEstablished during surveillance procedure (following national guidelines - between 6 months to 5 years)
Polyp recurrence rate for > 10mm polypsEstablished during surveillance procedure (following national guidelines - between 6 months to 5 years)
Residual polyp rate after CARMA technique with cold snareEstablished during index procedure

Countries

Australia

Contacts

Primary ContactAlexander Huelsen, MD
alexander.huelsenkatz@health.qld.gov.au+61 7 3176 2111

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026